Hye Jin Chung1, Hae-Young Park2, Su-Young Kim2. 1. HanGil Eye Hospital, Incheon 403-010, Korea. 2. Department of Ophthalmology and Visual Science, College of Medicine, the Catholic University of Korea, Seoul 137-701, Korea.
Abstract
AIM: To evaluate the outcome of laser iridotomy using 532-nm Nd: YAG laser (PASCAL) with short pulse duration and Nd: YAG laser compared to conventional combined laser iridotomy. METHODS: Retrospective, nonrandomized, comparative case series. Forty-five eyes of 34 patients underwent laser iridotomy. Twenty-two eyes underwent iridotomy using short duration PASCAL and Nd: YAG laser, and 23 eyes underwent iridotomy using conventional combined laser method. The average settings of PASCAL were 60 µm and 700-900 mW with a short duration of 0.01s to reduce the total applied energy. The conventional laser was 50 µm and 700-900 mW for 0.1s. After photocoagulation with these laser, the Nd: YAG laser was added in each group. Endothelial cell counts of pre-iridotomy and 2mo after iridotomy were measured and compared. RESULTS: All eyes completed iridotomy successfully. The total energy used in the PASCAL group was 1.85±1.17 J. Compared to conventional laser 13.25±1.67 J, the energy used was very small due to the short exposure time of PASCAL. Endothelial cell counts were reduced by 0.88% in the PASCAL group and 6.72% in the conventional laser group (P=0.044). The change in corneal endothelial cell counts before and after iridotomy was significant in conventional combined laser iridotomy group (P=0.004). CONCLUSION: Combined PASCAL and Nd:YAG laser iridotomy is an effective and safe technique in the dark brown irides of Asians. Furthermore, the short duration of exposure in PASCAL offers the advantages of reducing the total energy used and minimizing the corneal damage.
AIM: To evaluate the outcome of laser iridotomy using 532-nm Nd: YAG laser (PASCAL) with short pulse duration and Nd: YAG laser compared to conventional combined laser iridotomy. METHODS: Retrospective, nonrandomized, comparative case series. Forty-five eyes of 34 patients underwent laser iridotomy. Twenty-two eyes underwent iridotomy using short duration PASCAL and Nd: YAG laser, and 23 eyes underwent iridotomy using conventional combined laser method. The average settings of PASCAL were 60 µm and 700-900 mW with a short duration of 0.01s to reduce the total applied energy. The conventional laser was 50 µm and 700-900 mW for 0.1s. After photocoagulation with these laser, the Nd: YAG laser was added in each group. Endothelial cell counts of pre-iridotomy and 2mo after iridotomy were measured and compared. RESULTS: All eyes completed iridotomy successfully. The total energy used in the PASCAL group was 1.85±1.17 J. Compared to conventional laser 13.25±1.67 J, the energy used was very small due to the short exposure time of PASCAL. Endothelial cell counts were reduced by 0.88% in the PASCAL group and 6.72% in the conventional laser group (P=0.044). The change in corneal endothelial cell counts before and after iridotomy was significant in conventional combined laser iridotomy group (P=0.004). CONCLUSION: Combined PASCAL and Nd:YAG laser iridotomy is an effective and safe technique in the dark brown irides of Asians. Furthermore, the short duration of exposure in PASCAL offers the advantages of reducing the total energy used and minimizing the corneal damage.
Authors: Mahiul M K Muqit; George R Marcellino; David B Henson; Lorna B Young; Niall Patton; Stephen J Charles; George S Turner; Paulo E Stanga Journal: Acta Ophthalmol Date: 2011-12-16 Impact factor: 3.761
Authors: Hae-Young Lopilly Park; Na Young Lee; Chan Kee Park; Man Soo Kim Journal: Graefes Arch Clin Exp Ophthalmol Date: 2012-03-23 Impact factor: 3.117
Authors: Yannis M Paulus; Atul Jain; Hiroyuki Nomoto; Christopher Sramek; Ray F Gariano; Dan Andersen; Georg Schuele; Loh-Shan Leung; Theodore Leng; Daniel Palanker Journal: Retina Date: 2011-02 Impact factor: 4.256
Authors: Jeffrey Chi Wang Chan; Bonnie Nga Kwan Choy; Orlando Chia Chieh Chan; Kenneth Kai Wang Li Journal: Graefes Arch Clin Exp Ophthalmol Date: 2017-12-07 Impact factor: 3.117